Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Revenue (2021 - 2026)

Lucid Diagnostics filings provide 5 years of Revenue readings, the most recent being $1.5 million for Q4 2025.

  • On a quarterly basis, Revenue rose 25.31% to $1.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.7 million, a 8.79% increase, with the full-year FY2025 number at $4.7 million, up 8.15% from a year prior.
  • Revenue hit $1.5 million in Q4 2025 for Lucid Diagnostics, up from $1.2 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $1.5 million in Q4 2025 to a low of $76000.0 in Q3 2022.
  • Median Revenue over the past 5 years was $828000.0 (2025), compared with a mean of $728176.5.
  • Biggest five-year swings in Revenue: tumbled 62.67% in 2022 and later skyrocketed 930.26% in 2023.
  • Lucid Diagnostics' Revenue stood at $300000.0 in 2021, then tumbled by 62.67% to $112000.0 in 2022, then skyrocketed by 828.57% to $1.0 million in 2023, then rose by 15.1% to $1.2 million in 2024, then grew by 25.31% to $1.5 million in 2025.
  • The last three reported values for Revenue were $1.5 million (Q4 2025), $1.2 million (Q3 2025), and $1.2 million (Q2 2025) per Business Quant data.